Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Precursor Cell Lymphoblastic Leukemia-Lymphoma × eryaspase × Clear all

Status

No longer available 1 Completed 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

fludarabine phosphate 2 venetoclax 1 nilotinib 1 navitoclax 1 fludarabine 1 eryaspase 1 asparaginase erwinia chrysanthemi recombinant 1 Whole-Body Irradiation 1 Tacrolimus 1 Mycophenolic Acid 1 Cytarabine 1 Cyclophosphamide 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1 Bone Marrow Transplantation 1 Asparaginase 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02197650 2018-12-04

EAP

ERYtech Pharma

No longer available

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡